Recent Post
Peter Mac streamlines cancer treatment planning with deployment of Varian solution
Varian is today (Wednesday, October 3, 2018) announcing the installation of a cloud-hosted deployment of the Varian Eclipse™ treatment planning system and Velocity™ oncology imaging informatics system across five Peter MacCallum Cancer Centre (Peter Mac) sites in Victoria, Australia. Peter Mac is one of the world’s leading cancer research, education and treatment centres. It operates…
Read MoreNew report card on Aussie blokes health + wellness
Findings from a bodyandsoul-commissioned YouGov Galaxy survey released Sunday, September 2, 2018 provide some quirky insights into the current state of Aussie men’s health and wellness. According to the online survey, which captured responses from more than 1,000 men Australia-wide: 68 per cent of respondents had undergone a blood pressure check and 59 per cent…
Read MoreEvery drop counts – World Water Week 2018
This week is the World Water Week (WWW) Forum 2018 and this year’s focus is on ‘Water, ecosystems and human development’. Every year, WWW provides a platform for over 300 organisations to consider the latest research and encourage new thinking and positive action towards water-related issues worldwide. Around 1.1 billion people around the world do not…
Read MoreDoctors sound alarm bell at lack of qualified nurses in aged care sector
Doctors have this week raised an alarm regarding the lack of qualified nurses working in the Australian aged care sector. According to the AMA’s most recent Aged Care survey, 35% of doctor respondents plan to stop accepting new patients, to reduce or completely cease their aged-care visits within the next two years. The survey involved…
Read MorePharmaxis granted FDA clearance to produce Aridol locally for US market
ASX-listed pharmaceutical company, Pharmaxis has today been granted FDA clearance to commence Sydney-based production of its asthma diagnostic medication, Aridol for the US. The approval follows hot-on-the-heels of the FDA’s recent inspection of the Sydney facility which manufactures Aridol for Australia, South Korea and Europe, and Bronchitol for Australia, Europe and Russia respectively. Following FDA…
Read More